You are here

Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty

Last updated on February 22, 2019

FOR MORE INFORMATION
Study Location
Chicago, Illinois, United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Scar Prevention
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-45 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Subjects must have sufficient excess abdominal tissue to qualify for a standard
elective abdominoplasty

- Subject has chosen to have an elective abdominoplasty

- Medically healthy with normal screening results

- Subjects must not be pregnant or lactating

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects with existing scars or significant striae on the abdominal pannus

- Females who are currently pregnant or pregnant during the 12 months prior to inclusion
in the study, or lactating

- Participation in another clinical trial within 30 days prior to the start of the study

- Any other condition or prior therapy, which, in the opinion of the PI, would make the
subject unsuitable for this study

NCT01038297
Pfizer
Completed
Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now